Identification of Predictive Biomarkers Based on Cytokine Profiles for Molecular Relapse After Treatment-Free Remission in Chronic Myeloid Leukemia Patients

Tyrosine kinase inhibitors (TKIs) have transformed chronic myeloid leukemia (CML) into a manageable disease, and discontinuation has become a feasible goal for many patients. However, molecular relapse after TKI cessation remains a challenge. This study investigated factors influencing molecular rel...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন

প্রধান লেখক:	Bianca Vasconcelos Cordoba, Carolina Pavlovsky, María Belén Sanchez, Elena Beatriz Moiraghi, Ana Ines Varela, Miguel Arturo Pavlovsky, Isabel Amanda Giere, Franco Federico Freilich, Isolda Fernandez, Maria José Mela Osório, Ricardo Khalil Tannuri, Federico Sackmann, Mariana Juni, Georgina Emilia Bendek Del Prete, Eduardo Oscar Bullorsky, Juan Dupont, Josefina Freitas, Verónica Ventriglia, Ana Garcia Labanca, Romina Mariano, Carina Gumpel, Etelvina Macchiavello, Pedro Negri Aranguren, Mariano Paoletti, Francisca Rojas, Maria Fernanda Tosin, Marta Catalan, Maria del Rosario Custidiano, Maria Cecilia Foncuberta, Julio Cesar Sánchez Ávalos, Silvia Miranda, José Mordoh, Estrella Mariel Levy, Michele Bianchini
বিন্যাস:	Artigo
ভাষা:	Inglês
প্রকাশিত:	MDPI AG 2026-04-01
মালা:	Cells
বিষয়গুলি:	chronic myeloid leukemia treatment-free remission cytokine profiling immune biomarkers MCP-1 IL-6
অনলাইন ব্যবহার করুন:	https://www.mdpi.com/2073-4409/15/9/791
ট্যাগগুলো:	ট্যাগ যুক্ত করুন কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!